NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Regenasome Pty Ltd

Regenasome Pty Ltd

Private
MelbourneHealthcare & Life Scienceshttps://regenasome.com

Last Round

Pre Seed

Sep 18, 2025

Total Funding Raised

$830,000

Company Overview

Regenasome Pty Ltd is a biotechnology company that develops exosome-based therapies for the treatment of fibrotic and lung diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Space Technology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

exosome therapyregenerative medicineanti-aginglongevity researchexosome analysisnutraceuticalsbiotechnologybiohackinghealthspan extensionfunctional foodsspace medicinecosmeceuticalsprecision medicineclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regenasome Pty Ltd Comparables

Compare Regenasome Pty Ltd with similar companies based on industry and business-model similarity.

Regenasome Pty Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ExoCoBio
72%
VivaZome Therapeutics
61%
Aegle Therapeutics Corp
55%

Regenasome Pty Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 18, 2025
DebtMay 1, 2025
Pre SeedOct 22, 2024

Regenasome Pty Ltd Investors

Notable investors and investment history

Regenasome Pty Ltd investors
InvestorRounds
Leave a Nest CapitalPre Seed

Regenasome Pty Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Regenasome Pty Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Regenasome Pty Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Year Founded2018
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.